HCW Biologics Inc. SEC filings HCWB
HCW Biologics Inc. has 340 filings in SEC EDGAR's recent list, going back to Oct 19, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 24, 2026 (material agreement, unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Sep 24, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Sep 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Restatement
|
Aug 14, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 30, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 26, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 1, 2026 | May 29, 2026 |
| 8-K |
Current report
Agreement ended
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Other events
|
Apr 30, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 17, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 2, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 19, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 13, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 31, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 20, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 19, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 18, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 16, 2025 | Oct 13, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 5, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 19, 2025 | Aug 19, 2025 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 18, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 15, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 1, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 23, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Other events
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 4, 2025 | May 29, 2025 |
| 8-K |
Current report
Other events
|
May 30, 2025 | May 28, 2025 |
| 8-K |
Current report
Other events
|
May 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Other events
|
May 20, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
May 15, 2025 | May 13, 2025 |
| 8-K |
Current report
Other events
|
Apr 22, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 14, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 1, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 1, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 19, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 6, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 21, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Feb 7, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Dec 23, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Other events
|
Nov 22, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Auditor change
|
Sep 20, 2024 | Sep 20, 2024 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Aug 23, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 12, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Restatement
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Other events
|
May 1, 2024 | Apr 25, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 22, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Agreement ended
|
Jan 12, 2024 | Jan 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 29, 2023 |
| 8-K |
Current report
Other events
|
Aug 24, 2023 | Aug 22, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Other events
|
Jun 14, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 27, 2023 | Apr 21, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Other events
|
Dec 7, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 18, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2022 | May 19, 2022 |
| 8-K |
Current report
Results of operations
|
May 13, 2022 | May 13, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 24, 2022 | Jan 24, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2021 | Oct 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2021 | Oct 27, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2021 | Aug 13, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 26, 2021 | Jul 22, 2021 |
Showing 98 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HCWB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miramar, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1828673
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.